• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

SMS: Announces sale of MRI scanner to recurring customer in Ukraine

SMSMEDAnalyst Comment04.08.2026 klo 14.15
Victor SkriverEquity Research Assistant

Summary

  • Scandinavian Medical Solutions (SMS) announced the sale of an MRI scanner to a recurring customer in Ukraine, valued at DKK 2.0-3.5 million, marking the second high-end system delivered to this customer within the past year.
  • For the financial year 2025/26, SMS has announced new sales orders totaling DKK 43.5-69.5 million, compared to DKK 85.5-133.5 million in the same period of the previous financial year.
  • The lower order intake aligns with SMS's revised guidance, which remains unchanged at DKK 190-220 million in sales and EBITDA of DKK 0-5 million for the financial year 2025/26.
  • HC Andersen Capital receives payment from SMS for a Digital IR subscription agreement, as disclosed by Victor Skriver.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Automatic translation: Originally published in undefined 04/08/2026, 11:15 GMT. Give feedback here.

Scandinavian Medical Solutions (SMS) today announced the sale of an MRI scanner to an existing customer in Ukraine. The order is valued at DKK 2.0-3.5 million and was made with a customer who purchased a high-end system from SMS last year. SMS has now delivered two high-end systems to the recurring Ukrainian customer within the past year. The equipment was handed over in week 28, 2026.

In total, the company has announced new sales to the market (only orders above DKK 2 million) of between DKK 43.5-69.5 million in the financial year 2025/26 (October 1, 2025, to date, August 4, 2026). In the same period of the financial year 2024/25 (October 1, 2024, to August 4, 2025), SMS announced orders of between DKK 85.5-133.5 million. The lower announced order intake is in line with the company's revised guidance, and the order does not change the announced guidance for sales of DKK 190-220 million and EBITDA of DKK 0-5 million for the financial year 2025/26. It should be noted that the number and size of unannounced agreements under DKK 2 million are not known. Likewise, individual orders may have been included in other accounting periods depending on the timing of the risk transfer.

Disclaimer: HC Andersen Capital receives payment from Scandinavian Medical Solutions for a Digital IR subscription agreement. /Victor Skriver, 13:15, 04/08-2026.

Login required

This content is only available for logged in users

Create account

Scandinavian Medical Solutions is a Danish-based trading company specialized in purchase and resale of used diagnostic imaging equipment such as CT scanners and MR scanners of high quality. Scandinavian Medical Solutions is specialized in offering flexible solutions for customers with specific demands, which is often a better and cheaper alternative to a new and more expensive produced OEM-equipment. Scandinavian Medical Solutions was founded in 2018, and the company has been listed at Nasdaq First North in Denmark since November 2021.

Read more on company page